pentobarbital will lessen the level or effect of erlotinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Contraindicated (one)pentobarbital will reduce the level or result of doravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or impact of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.
pentobarbital will lower the level or impact of fesoterodine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the extent or result of colchicine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will reduce the level or outcome of theophylline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lower the level or effect of ambrisentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will lessen the extent or result of estradiol vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will reduce the level or effect of etravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the extent or effect of here bexarotene by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or result of diazepam buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Powerful or average CYP3A4 inducers might raise price of diazepam elimination; hence, efficacy of diazepam could be diminished.
fentanyl transdermal and pentobarbital both increase sedation. Avoid or Use Alternate Drug. Restrict use to people for whom option therapy choices are inadequate
Since the Victorian Authorities considers suggestions to legalise assisted dying, a single woman fights for her suitable to have a option.
pentobarbital will reduce the extent or impact of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.